By John Breeding| 2017-10-13T21:44:16+00:00 June 28th, 2017|Editorials, Electroshock|
Despite its claim to virtue as a government regulatory agency whose mission is to protect the public, in truth the Food and Drug Administration (FDA) all too often functions as an industry ally—and the agency’s history and current avoidance of responsibility with electroshock (also known as ECT) is an egregious example.
By Kenneth Castleman| 2017-10-16T18:46:29+00:00 June 23rd, 2017|Electroshock, News, Topics|
A recent study was published in Progress in Neurology and Psychiatry by consultant psychiatrist Latha Guruvaiah and colleagues. It recorded patients’ and their caregivers’ experiences and attitudes toward ECT following their treatment. However, it is no more than a patient satisfaction survey at one institution and adds nothing to the debate about the safety and effectiveness of ECT, except to confirm, once again, that ECT causes headaches, confusion, and memory loss.
